We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

223 hedge funds and large institutions have $6.51B invested in Vaxcyte in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 86 increasing their positions, 69 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

236% more call options, than puts

Call options by funds: $9.9M | Put options by funds: $2.94M

131% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 16

26% more capital invested

Capital invested by funds: $5.17B → $6.51B (+$1.34B)

25% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 69

10% more funds holding

Funds holding: 202 → 223 (+21)

8% more funds holding in top 10

Funds holding in top 10: 13 → 14 (+1)

0.88% more ownership

Funds ownership: 108.03% → 108.91% (+0.88%)

Holders
223
Holders Change
+21
Holders Change %
+10.4%
% of All Funds
3.25%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.2%
New
37
Increased
86
Reduced
69
Closed
16
Calls
$9.9M
Puts
$2.94M
Net Calls
+$6.96M
Net Calls Change
+$6.35M

Top Buyers

1
BlackRock
BlackRock
New York
+$60M
2
Morgan Stanley
Morgan Stanley
New York
+$34.5M
3
DGM
Darwin Global Management
Jersey
+$30.1M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$23.5M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$20M

Top Sellers

1
MVM
Medicxi Ventures Management
Jersey
-$53.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$32.3M
3
FAM
Fred Alger Management
New York
-$22M
4
NIP
Nicholas Investment Partners
California
-$18.1M
5
B
Braidwell
Connecticut
-$17.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
51
Samlyn Capital
New York
$20.7M +$17.1M +329,209 New
Amundi
52
Amundi
France
$20M -$682K -13,124 -4%
TCM
53
Tang Capital Management
California
$18.8M – – –
N
54
Nuveen
North Carolina
$17.6M -$808K -15,556 -5%
PHP
55
Parkman Healthcare Partners
Connecticut
$16.8M +$1.53M +29,462 +12%
EP
56
Eversept Partners
New York
$14.7M +$2.25M +43,409 +23%
PI
57
Putnam Investments
Massachusetts
$14.3M +$6.27M +120,705 +113%
Invesco
58
Invesco
Georgia
$14.3M +$3.92M +75,386 +50%
PAMP
59
Polar Asset Management Partners
Ontario, Canada
$13.5M -$5.78M -111,300 -34%
Barclays
60
Barclays
United Kingdom
$12.7M +$1.62M +31,286 +18%
PC
61
Pier Capital
Connecticut
$12.7M -$112K -2,166 -1%
Aberdeen Group
62
Aberdeen Group
United Kingdom
$12.2M +$10.1M +194,232 New
Comerica Bank
63
Comerica Bank
Texas
$11.8M +$5.27M +101,407 +117%
VOYA Investment Management
64
VOYA Investment Management
Georgia
$11.5M +$71.9K +1,384 +0.8%
Bank of America
65
Bank of America
North Carolina
$10.9M -$1.87M -35,982 -17%
TD Asset Management
66
TD Asset Management
Ontario, Canada
$10.5M +$825K +15,890 +11%
UBS Group
67
UBS Group
Switzerland
$10.4M +$4.76M +91,729 +123%
SBH
68
Segall Bryant & Hamill
Illinois
$10.1M +$8.32M +160,281 New
Rafferty Asset Management
69
Rafferty Asset Management
New York
$9.95M -$285K -5,481 -3%
Deutsche Bank
70
Deutsche Bank
Germany
$9.56M +$4.01M +77,179 +103%
Adage Capital Partners
71
Adage Capital Partners
Massachusetts
$9.43M +$935K +18,000 +14%
MAP
72
Moody Aldrich Partners
Massachusetts
$9.29M +$403K +7,757 +6%
Swiss National Bank
73
Swiss National Bank
Switzerland
$9.29M -$343K -6,600 -4%
SSA
74
Schonfeld Strategic Advisors
New York
$8.37M -$6.89M -132,733 -50%
RhumbLine Advisers
75
RhumbLine Advisers
Massachusetts
$8.2M +$12.5K +241 +0.2%
1 2
3
4 5

PCVX Hedge Fund Activity: Q4 2023 in Review

223 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q4 2023, worth a combined $6.51B — up 26% from $5.17B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCVX positions and 16 closed out — a net gain of 21 holders — while 86 added to existing stakes and 69 trimmed.

The largest buyer was BlackRock, adding an estimated $60M. The largest seller was Medicxi Ventures Management, exiting entirely with an estimated $53.5M sold.

  • 223 institutional investors held Vaxcyte (PCVX) as of Q4 2023, up from 202 in Q3 2023.
  • Funds reported $6.51B of Vaxcyte stock for Q4 2023, up 26% quarter-over-quarter.
  • 37 funds opened new Vaxcyte positions in Q4 2023 and 16 closed out, a net change of +21 holders.
  • The largest Vaxcyte buyer in Q4 2023 was BlackRock, an estimated $60M added.
  • The largest Vaxcyte seller in Q4 2023 was Medicxi Ventures Management, an estimated $53.5M sold.

Based on aggregated 13F filings for Q4 2023.